2026-02-14 · 5 min read
Novo Nordisk's CagriSema Declared 'Obsolete' After Failed Trials
In a dramatic shift for the pharmaceutical industry, Novo Nordisk, the pioneering force behind blockbuster weight loss drugs like...
Read More →
2026-02-17 · 7 min read
Weight Loss War: Eli Lilly's Zepbound Outperforms Novo Nordisk
The pharmaceutical landscape for weight management is undergoing a dramatic transformation, marked by intense competition and...
Read More →
2026-02-20 · 5 min read
Novo Nordisk Faces Pivot Calls After CagriSema Market Setback
For years, Novo Nordisk has been a titan in the pharmaceutical world, particularly synonymous with groundbreaking advancements in...
Read More →